MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Breese BB et al. | The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V. | 1977 | Clin Pediatr (Phila) | pmid:403044 |
Pessayre D and Benhamou JP | Hepatotoxicity of erythromycin derivatives. | 1979 | Br Med J | pmid:445081 |
Drew R and Piestly BG | Effect of chlorpromazine and erythromycin on bile salt-induced cholestasis in the rat. | 1979 | Pharmacology | pmid:572556 |
Welling PG et al. | Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate. | 1979 | J Pharm Sci | pmid:423080 |
Krowchuk D and Seashore JH | Complete biliary obstruction due to erythromycin estolate administration in an infant. | 1979 | Pediatrics | pmid:514726 |
Chen KC et al. | Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. | 1979 | J. Clin. Invest. | pmid:447831 |
Selenke WM et al. | Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects. | 1980 | J. Allergy Clin. Immunol. | pmid:6966289 |
Henry J et al. | Plasma and salivary concentrations of erythromycin after administration of three different formulations. | 1980 | Postgrad Med J | pmid:7220406 |
DiSanto AR et al. | Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. | 1980 | J Clin Pharmacol | pmid:7430412 |
Dujovne CA and Salhab AS | Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. | 1980 | Pharmacology | pmid:7403251 |